Stockscreener 앱 받기
70.00
1.35%
0.93
전일 마감가:
$69.07
열려 있는:
$68.81
하루 거래량:
299.25K
Relative Volume:
1.46
시가총액:
$467.78M
수익:
-
순이익/손실:
$-7.12M
주가수익비율:
-30.43
EPS:
-2.3
순현금흐름:
$-6.82M
1주 성능:
+11.11%
1개월 성능:
-2.06%
6개월 성능:
+70.44%
1년 성능:
+129.66%
1일 변동 폭
$67.62
$72.01
1주일 범위
$57.86
$72.01
52주 변동 폭
$26.05
$105.00
Monopar Therapeutics Inc Stock (MNPR) Company Profile
명칭
Monopar Therapeutics Inc
전화
(847) 388-0349
주소
1000 SKOKIE BLVD SUITE 350, WILMETTE
MNPR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
MNPR
Monopar Therapeutics Inc
|
70.00 | 461.57M | 0 | -7.12M | -6.82M | -2.30 |
|
VRTX
Vertex Pharmaceuticals Inc
|
441.36 | 111.36B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
733.04 | 77.98B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ARGX
Argen X Se Adr
|
800.01 | 50.33B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
359.27 | 47.46B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ONC
Beone Medicines Ltd Adr
|
338.19 | 37.43B | 4.98B | 69.59M | 525.67M | 0.5197 |
Monopar Therapeutics Inc Stock (MNPR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-09 | 개시 | Morgan Stanley | Overweight |
| 2025-11-14 | 다운그레이드 | Raymond James | Strong Buy → Outperform |
| 2025-11-10 | 개시 | Leerink Partners | Outperform |
| 2025-10-13 | 개시 | Barclays | Overweight |
| 2025-09-09 | 개시 | BTIG Research | Buy |
| 2025-09-03 | 개시 | Oppenheimer | Outperform |
| 2025-09-03 | 개시 | Raymond James | Strong Buy |
| 2025-08-26 | 재개 | H.C. Wainwright | Buy |
| 2025-07-07 | 개시 | Cantor Fitzgerald | Overweight |
| 2025-06-23 | 개시 | Chardan Capital Markets | Buy |
| 2025-03-19 | 재개 | Piper Sandler | Overweight |
| 2025-01-10 | 개시 | Piper Sandler | Overweight |
| 2024-10-11 | 개시 | Rodman & Renshaw | Buy |
| 2021-01-28 | 개시 | ROTH Capital | Buy |
모두보기
Monopar Therapeutics Inc 주식(MNPR)의 최신 뉴스
Fundamentals Check: Why is Monopar Therapeutics Inc stock going downJuly 2025 Recap & Trade Opportunity Analysis Reports - baoquankhu1.vn
Technical Reactions to MNPR Trends in Macro Strategies - Stock Traders Daily
Price Action: Is Monopar Therapeutics Inc impacted by rising rates2025 Risk Factors & Short-Term High Return Ideas - baoquankhu1.vn
History Review: Is CO2 Energy Transition Corp a stock for growth or value investors2025 Geopolitical Influence & High Win Rate Trade Tips - baoquankhu1.vn
BTIG Reiterates Buy Rating for MNPR with $104 Target Price | MNP - GuruFocus
Monopar Therapeutics' (MNPR) "Buy" Rating Reiterated at BTIG Research - MarketBeat
3 ‘Strong Buy’ Stocks to Buy Today, 1/14/2026, According to Top Analysts - TipRanks
BTIG reiterates Buy rating on Monopar Therapeutics stock ahead of NDA submission - Investing.com Canada
Momentum Shift: How strong is Monopar Therapeutics Inc stock balance sheetMarket Volume Summary & Technical Entry and Exit Alerts - Bộ Nội Vụ
Aug Closing: Is Monopar Therapeutics Inc. stock a safe investment in uncertain marketsWeekly Earnings Recap & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Sentiment Recap: Is Monopar Therapeutics Inc. stock a safe haven assetInflation Watch & Reliable Intraday Trade Alerts - Bộ Nội Vụ
CEO Moves: How cyclical is Monopar Therapeutics Inc. (1IY0) stock compared to rivals2025 Institutional Moves & Daily Market Momentum Tracking - Bộ Nội Vụ
How dovish Fed policy supports Monopar Therapeutics Inc. (1IY0) stock2025 Market WrapUp & Weekly Watchlist for Hot Stocks - Улправда
Monopar Therapeutics (NASDAQ:MNPR) Rating Lowered to “Sell” at Wall Street Zen - Defense World
Monopar Therapeutics initiated with an Overweight at Morgan Stanley - TipRanks
Morgan Stanley Initiates Coverage on Monopar Therapeutics (MNPR) - GuruFocus
Morgan Stanley initiates Monopar Therapeutics stock with Overweight rating By Investing.com - Investing.com Canada
Why Monopar Therapeutics Inc. stock appeals to analystsPrice Action & Daily Growth Stock Tips - ulpravda.ru
Monopar Therapeutics Inc. (NASDAQ:MNPR) Receives Average Rating of “Buy” from Brokerages - Defense World
Can Monopar Therapeutics Inc. stock maintain operating marginsTrade Exit Report & Free Low Drawdown Momentum Trade Ideas - ulpravda.ru
How risky is Monopar Therapeutics Inc. stock nowWeekly Investment Recap & Free Community Consensus Stock Picks - Улправда
symbol__ Stock Quote Price and Forecast - CNN
Will Monopar Therapeutics Inc. stock return to pre crisis levelsJuly 2025 News Drivers & Fast Moving Stock Watchlists - Улправда
Can Monopar Therapeutics Inc. stock hit record highs again2025 Macro Impact & Weekly Return Optimization Alerts - Улправда
Published on: 2026-01-09 02:26:30 - ulpravda.ru
Published on: 2026-01-09 02:04:15 - Улправда
Will Monopar Therapeutics Inc. stock keep outperforming rivalsEntry Point & Low Risk Investment Opportunities - Улправда
Will Monopar Therapeutics Inc. stock gain from strong economyWeekly Trade Analysis & Capital Efficient Trade Techniques - ulpravda.ru
Published on: 2026-01-09 00:02:11 - ulpravda.ru
Published on: 2026-01-08 22:24:28 - Улправда
Trading the Move, Not the Narrative: (MNPR) Edition - Stock Traders Daily
EPS Watch: What dividend safety score for Monopar Therapeutics Inc. stock2025 Momentum Check & Verified Swing Trading Watchlists - Bộ Nội Vụ
Monopar Therapeutics announces pricing of $135M offering - MSN
Aug Gainers: Why Monopar Therapeutics Inc stock appeals to analystsProfit Target & Fast Momentum Stock Entry Tips - moha.gov.vn
Hedge Fund Moves: Is Monopar Therapeutics Inc stock a buy for dividend growthSwing Trade & Technical Entry and Exit Alerts - moha.gov.vn
Top Executive Makes Bold Insider Move at Monopar Therapeutics - TipRanks
Insider Buying: Quan Vu Acquires Shares of Monopar Therapeutics Inc (MNPR) - GuruFocus
Monopar Therapeutics (NASDAQ:MNPR) CFO Purchases 1,500 Shares - MarketBeat
Monopar therapeutics CFO Vu Quan Anh buys $104925 in shares By Investing.com - Investing.com Canada
Insider Stock Purchases: December 29, 2025 | TPVG Stock News - Quiver Quantitative
Wall Street Analysts Predict a 51.26% Upside in Monopar Therapeutics (MNPR): Here's What You Should Know - MSN
Monopar Therapeutics Inc. (NASDAQ:MNPR) Short Interest Update - MarketBeat
Responsive Playbooks and the MNPR Inflection - Stock Traders Daily
What Awaits These 4 Biotech Stocks That More Than Doubled in 2025 - Zacks Investment Research
Independent Director Arthur Klausner Sold A Bunch Of Shares In Monopar Therapeutics - simplywall.st
What dividend safety score for Monopar Therapeutics Inc. stockStop Loss & AI Powered Buy and Sell Recommendations - Улправда
Major Insider Move Shakes Up Investor Watch on Monopar Therapeutics - TipRanks
Is Monopar Therapeutics Inc. stock a safe haven assetJuly 2025 Summary & Accurate Intraday Trading Signals - Улправда
Insider Sell: Arthur Klausner Sells Shares of Monopar Therapeuti - GuruFocus
Dir Klausner Files To Sell 5,121 Of Monopar Therapeutics Inc [MNPR] - TradingView — Track All Markets
Monopar Therapeutics Director Sells Over 5,000 Shares - TradingView — Track All Markets
Monopar Therapeutics Inc (MNPR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
4.73%
0.92%
자본화:
|
볼륨(24시간):